NA
The startup develops a DNA-based affinity test kit that analyzes genetic variants affecting drug metabolism, enabling personalized treatment plans for patients. This approach minimizes adverse drug reactions and enhances therapeutic efficacy by tailoring medications to individual genetic profiles.
Updated 3 months ago
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a DNA-based affinity test kit that analyzes genetic variants affecting drug metabolism, enabling personalized treatment plans for patients. This approach minimizes adverse drug reactions and enhances therapeutic efficacy by tailoring medications to individual genetic profiles.